Autor(es): Jorge, Paula Alexandra Silva ; Lourenço, Anália Maria Garcia ; Pereira, Maria Olívia
Data: 2012
Identificador Persistente: http://hdl.handle.net/1822/75799
Origem: RepositóriUM - Universidade do Minho
Projeto/bolsa: info:eu-repo/grantAgreement/FCT/5876-PPCDTI/113196/PT ;
[Excerpt] Introduction The solution to clinically relevant biofilms and antimicrobial resistance may lie in alternative products with new mechanisms of action. Antimicrobial peptides (AMPs) may be good replacements for current antibiotics because their action is low in specificity, reducing the chance of acquiring resistance, and they have a broad spectrum of activity against Gram-negative and -positive bacteria, including drug-resistant strains. Biofilms of Pseudomonas aeruginosa, a multidrug-resistant Gram-negative pathogen, are the second most common cause of nosocomial pneumonia and are also related to infections in medical devices. Synergic interrelationships between AMPs could be a promising perspective to treat these biofilm-associated infections.
The financial support from IBB-CEB, Fundação para a Ciência e Tecnologia (FCT) and European Community fund FEDER, through Program COMPETE, in the ambit of the FCT PTDC/SAU-SAP/113196/2009/FCOMP-01-0124-FEDER-016012 are gratefully acknowledged
info:eu-repo/semantics/publishedVersion
